Have you been diagnosed with Coeliac Disease?
We are now recruiting for the next phase of research on an experimental vaccine therapy to treat Coeliac Disease.
Currently, the only way to manage the disease is by the lifelong and strict avoidance of gluten in the diet, as even small amounts of gluten can cause gastrointestinal damage and related symptoms. A gluten-free diet is exceptionally demanding for patients, expensive, and can be difficult to maintain as gluten is used extensively in modern food production.
Our study will explore whether the use of a novel vaccine therapy can switch off the immune response and restore gluten tolerance.
We are currently recruiting study participants who:
- Are between the ages of 18 and 70.
- Have been on a gluten free diet for at least 12 months.
- Have been medically diagnosed with Coeliac Disease, by biopsy.
- Are willing to attend approximately 20 clinic visits over a 6 month period.
To see if you are eligible complete the questionnaire below, or call the Clinical Trials Centre on 07 5456 3797.
Full title: A Phase 2, Randomised, Double-blind, Placebo-controlled Study in HLA-DQ2.5+ Adults with Coeliac Disease to Assess the Effect of Nexvax2 on Symptoms after Masked Gluten Food Challenge.
Ethics Approval: Bellberry Human Research Ethics Committee
If you experience difficulty completing the survey please email firstname.lastname@example.org